Skip to main content
Aurora Spine logo

Aurora Spine — Investor Relations & Filings

Ticker · ASG TSXV Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2025-04-11 Regulatory Filings
Country CA Canada
Listing TSXV ASG

About Aurora Spine

https://www.aurora-spine.com/

Aurora Spine designs and manufactures innovative, minimally invasive spinal implants and surgical solutions. The company's mission is to simplify complex spine and SI joint procedures, focusing on patient-centric devices for aging populations. Its comprehensive product portfolio addresses conditions across the Cervical, Thoracic, Lumbar, and SI joint regions. Core offerings include the patented ZIP family of interspinous process lumbar fusion devices, known for their screwless, less invasive design. Aurora Spine is also a vertically integrated provider, offering a comprehensive biologics portfolio alongside its implant systems.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 1% confidence The document is a TSX Trust Company notice confirming the mailing of a Notice of Record and Meeting Dates for an upcoming Annual and Special Meeting of security holders. It does not include proxy materials themselves, voting results, dividend information, or financial data; instead it’s a general regulatory notification concerning shareholder meeting logistics. This most closely aligns with a general regulatory announcement rather than a full proxy statement or AGM materials. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2025-04-11 English
News release - English.pdf
Remuneration Information Classification · 1% confidence The document is an ASX announcement titled “Managing Director and CEO Retention Plan,” detailing a variation of the executive services agreement (i.e., changes to fixed remuneration) and an issuance of retention shares to the Managing Director & CEO. It focuses on executive compensation rather than a broader financial report, capital raising from investors, or director appointments. This aligns with the Remuneration Information category (reporting on compensation for top executives and directors).
2025-04-02 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate news release announcing the company’s attendance at a medical conference (AAOS Annual Meeting). It contains product descriptions and forward-looking statements, but no financial results, not a proxy, not a report publication, and not any other specific filing type. It is a general announcement that would typically be filed as a miscellaneous regulatory release. Therefore, it falls under the fallback category ‘Regulatory Filings’ (RNS).
2025-03-11 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the completion of patient enrollment in a clinical study (REFINE) and outlining future presentation plans. It contains no financial results, no shareholder meeting details, no capital transactions, no governance or legal notices, and is not a full report but a business update. It doesn’t fit any specific categories such as earnings release, annual report, M&A, or dividend notice. Therefore, it falls into the fallback category for miscellaneous regulatory announcements.
2025-03-10 English
News release - English.pdf
Regulatory Filings
2024-10-25 English
Interim MD&A - English.pdf
Regulatory Filings
2024-10-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.